Vitiligo
Vitiligo is a skin condition that causes loss of skin color in patches, resulting from the destruction of pigment-producing cells. It can affect any part of the body and may lead to changes in skin tone.
Vitiligo Treatment: Targeting TYK2 Responses
We are exploring a new treatment aimed at improving skin color in people with vitiligo. This study will help us understand if targeting specific responses can be beneficial.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
Dermatologie
Bordeaux, France
Assistance Publique Hopitaux De Paris
Dermatologie
Créteil, France
Centre Hospitalier Universitaire De Lille
Dermatologie
Loos, France
Sponsor: Centre Hospitalier Universitaire De Nice
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.